Staff costs dragging big pharma down

By Kirsty Barnes

- Last updated on GMT

Related tags Pharmaceutical industry

As financial pressures continue to plague the pharma industry,
firms should consider taking more advantage of sourcing staff in
cheap labour markets in order to save a buck.

This was the message of financial analyst Stewart Atkins, speaking at the recent "Change management" meeting in the UK, run by contract sales organisation (CSO) Innovex and the Association of the British Pharmaceutical Industry (ABPI).

As generic drugs continue to storm the market at the expense of branded drugs, the pharma industry is facing staggering losses in sales of $40bn (€31.3bn) over the next two years alone due to patent expiries.

Atkins points out that staff costs are currently carving a large chunk out of drug company profits and this should be a key area of focus in the industry's bid to cut costs and offset eroding sales.

"Approximately 35 per cent of costs in the industry are employee costs, representing about 25 per cent of total sales - on average about $100,000 per person,"​ said Atkins.

"Sales per employee are now $350,000, but a 25 per cent cut in drug prices would see profits per person shrink dramatically to $12,000."

The average large drug company in Europe employs 84,000 people to the tune of $7.8bn a year.

Atkins mused that if 70 per cent of production staff, 30 per cent of R&D staff and 20 per cent of admin staff were used from cheaper markets such as India and China, $1.1bn a year could be saved, adding four per cent to profit margins.

"Although highly unlikely in the near term, this scenario should certainly be considered by pharma firms when it comes to making new investment."

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers

Follow us


View more